Viewing Study NCT04694560

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:05 AM
Ignite Modification Date: 2026-02-06 @ 6:48 AM
Study NCT ID: NCT04694560
Status: WITHDRAWN
Last Update Posted: 2025-05-16
First Post: 2020-12-28
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: A Time-Limited Approach to Treatment With Ibrutinib for Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma
Sponsor: Memorial Sloan Kettering Cancer Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Chronic Lymphocytic Leukemia View
None Small Lymphocytic Lymphoma View
None CLL View
None SLL View
None CLL/SLL View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Small Lymphocytic Lymphoma View
None Chronic Lymphocytic Leukemia View
None CLL/SLL View
None SLL View
None CLL View
None Ibrutinib View
None Ibrutinib monotherapy View
None anti-CD20 monoclonal antibody View
None MRD View
None U-MRD View
None 20-284 View
None Memorial Sloan Kettering Cancer Center View